Deseret News Share this story Lawrie Allred, HTS engineer, hands a cell plate to a co-worker while seeding cells at Recursion Pharmaceuticals at The Gateway in Salt Lake City on Oct. 30, 2018. This week, the company announced it will double the footprint of its flagship research and office facility, signing a lease on an additional 100,000 square feet of space at The Gateway. Kristin Murphy, Deseret News Utah biotech startup Recursion Pharmaceuticals is upending the realm of clinical-stage drug research, melding robot-driven automation with digital artificial intelligence on a mission to revolutionize how new medications are developed to battle some of the rarest and most challenging of human medical conditions.